Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,284 public trials 1,281 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

NCT03553836

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • University of Arizona Cancer Center ( Site 0121) Tucson, Arizona, United States
  • UCSD Moores Cancer Center ( Site 0133) La Jolla, California, United States
  • The Angeles Clinic and Research Institute ( Site 0029) Los Angeles, California, United States
  • UCLA Hematology & Oncology ( Site 0130) Los Angeles, California, United States
View all 159 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

NCT05561374

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +10 more
Locations
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

NCT02385214

Conditions
Cutaneous Melanoma by AJCC V7 Stage, Melanoma, Neoplasms, +10 more
Locations
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • Melanoma Institute Australia - Poche Centre North Sydney, New South Wales, Australia
  • Gold Coast Melanom Clinic Coolangatta, Queensland, Australia
  • Peter MacCallum Cancer Centre Division of Cancer Surgery Melbourne, Victoria, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

NCT04954001

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Principal Investigator Hans Gainesville, Florida, United States
  • John Hopkins All Children Hospital St. Petersburg, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
View all 14 locations
View Trial Details

Related conditions